Glycebose 0.2mg Tablet
Marketer
Cognitive Life Sciences Ltd
Salt Composition
Voglibose (0.2mg)
Overview Glycebose 0.2mg Tablet
Miglitol 0.2mg tablets are prescribed for managing type 2 diabetes. This medication aids in regulating postprandial hyperglycemia (elevated blood sugar after meals). It's indicated when dietary changes and other similar medications prove insufficient to control blood glucose levels. Administer Miglitol 0.2mg just before each meal; dosage and frequency should be determined by your physician for optimal glycemic control. Discontinue use only under medical supervision; abrupt cessation may lead to dangerously high blood sugar and serious complications like renal impairment and vision loss. This medication is part of a comprehensive treatment plan that includes a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Common side effects may include abdominal distension, stomach discomfort, decreased appetite, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Miglitol itself does not typically cause hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) elevates this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in these cases. Inform your doctor of any kidney or liver conditions before starting this medication. This medicine is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Always disclose all other medications to your doctor to ensure medication safety. Limit alcohol consumption while taking Miglitol to reduce the risk of hypoglycemia.
Primary Ingredients of Glycebose 0.2mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Glycebose 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Glycebose 0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glycebose 0.2mg Tablet on an empty stomach.
Common Side effects of Glycebose 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Glycebose 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glycebose 0.2mg Tablet on an empty stomach.
How Glycebose 0.2mg Tablet works:
Glycebose 0.2mg tablets are used to manage diabetes. Their action involves blocking intestinal enzymes that digest complex carbohydrates into easily absorbed glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glycebose 0.2mg tablets and alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of 0.2mg Glycebose tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Glycebose 0.2mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Glycebose 0.2mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Glycebose 0.2mg tablets, as dosage modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Glycebose 0.2mg tablets cautiously, as dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Glycebose 0.2mg Tablet :
Omit any missed Glycebose 0.2mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glycebose 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |
| Behavior Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently